BOTANIX PHARMACEUTICALS LTD

7.69%

30.0¢

Market Cap $588.2M

Healthcare Biotechnology

Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix... Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix (USA), committed to the development of novel treatments for common skin diseases and infections.More

FIREBRICK PHARMA

Invest in the Future of Healthcare – Firebrick Pharma’s Investor Webinar

Latest Threads

Tag

Subject

BOT

BOT - Anything but charting

262 263 264

12:12

15K

6.0M

12:12

Last post rae915

15K

6.0M

BOT

Bot Chart

352 353 354

07:55

21K

7.5M

07:55

Last post Justanovice

21K

7.5M

BOT

Short Tracker

2 3

06:23

163

51K

06:23

Last post Nooseman

163

51K

BOT

Ann: Botanix Signs Debt Facility with Kreos Capital

13/06/25

102

36K

13/06/25

Last post Sarge1000

102

36K

BOT

Ann: Notification regarding unquoted securities - BOT

11/06/25

608

11/06/25

Last post

ASX News

608

BOT

Reviews

2 3

10/06/25

162

69K

10/06/25

Last post beefarmer

162

69K

BOT

Ann: Proposed issue of securities - BOT

10/06/25

491

10/06/25

Last post

ASX News

491

BOT

Current And Future Valuation 2025

3 4 5

09/06/25

245

105K

09/06/25

Last post dahalb

245

105K

See All Discussions

Timeline

Notification regarding unquoted securities - BOT
11 Jun 18:07	Share

Proposed issue of securities - BOT
10 Jun 08:54	Share

Botanix Signs Debt Facility with Kreos Capital
10 Jun 08:39	Share

Final Director's Interest Notice - M. Callahan
23 May 09:06	Share

Director Update
23 May 08:18	Share

Notification of cessation of securities - BOT
21 May 17:23	Share

Application for quotation of securities - BOT
21 May 17:22	Share

Ceasing to be a substantial holder
14 May 16:39	Share

Response to ASX Price Query Letter
12 May 12:26	Share

Botanix Responds to US Pharmaceutical Pricing Announcement
12 May 12:26	Share

Pause in trading
12 May 10:48	Share

Change in substantial holding from IFL
06 May 17:38	Share

Becoming a substantial holder
01 May 16:37	Share

Section 708A(5)(e) Notice
24 Apr 17:29	Share

Application for quotation of securities - BOT
24 Apr 17:27	Share

March 2025 Quarterly Activities Report and Appendix 4C
24 Apr 14:05	Share

Botanix Webinar - 15 April 2025 - Registration Information
15 Apr 09:55	Share

Proposed issue of securities - BOT
15 Apr 09:51	Share

Botanix $40 Million Capital Raising for Sofdra Rollout
15 Apr 09:50	Share

Trading Halt
14 Apr 09:39	Share

Notification regarding unquoted securities - BOT
02 Apr 19:55	Share

Notification of cessation of securities - BOT
02 Apr 19:55	Share

Change of Director's Interest Notice - D. Sharp
21 Mar 18:37	Share

Notification of cessation of securities - BOT
21 Mar 18:30	Share

Application for quotation of securities - BOT
21 Mar 18:27	Share

Botanix Conference Commercial Update
11 Mar 08:23	Share

S&P DJI Announces March 2025 Quarterly Rebalance
07 Mar 17:01	Share

Notification regarding unquoted securities - BOT
07 Mar 13:59	Share

Section 708A(5)(e) Notice
28 Feb 09:48	Share

Change of Director's Interest Notice - S. Washer
28 Feb 09:47	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 30.0¢		Change -0.025(7.69%)		Mkt cap ! $588.2M

Open	High	Low	Value	Volume
33.0¢	33.5¢	30.0¢	$3.064M	9.775M

Buyers (Bids)

No.	Vol.	Price($)
19	449742	30.0¢

Sellers (Offers)

Price($)	Vol.	No.
30.5¢	30000	1

View Market Depth

No.	Vol.	Price($)
12	304387	0.300
16	236813	0.295
15	224655	0.290
4	46981	0.285
17	362084	0.280

Price($)	Vol.	No.
0.305	30000	1
0.310	40000	2
0.315	128409	3
0.320	418523	4
0.325	120000	1

Last trade - 16.10pm 13/06/2025 (20 minute delay)

BOT (ASX) Chart

BOTANIX PHARMACEUTICALS LTD

Latest Threads

Timeline

Featured News

Latest Articles

First Sofdra prescriptions for excessive sweating condition pushes Botanix towards full commercial launch

Botanix has reported the first prescriptions of its drug Sofdra (sofpironium) to treat hyperhidrosis, a condition of excessive sweating.

US FDA approves Botanix Pharma's excessive underarm sweat drug

Botanix on Thursday described itself as having transitioned from a development stage to being revenue-generating dermatology company.

Botanix isn't sweating on FDA approval for Sofdra

Botanix has submitted the last label materials to the FDA seeking approval for Sofdra™ a prescription treatment for underarm sweating.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News